Brady Corp: Form 10-Q for the period ended Apr 30, 2021
Filed with the SEC on May 20, 2021 and accepted by EDGAR at May 20, 2021, 07:18 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2021-04-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2021-02-01 to 2021-04-30 | $295.5m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 9 months2020-08-01 to 2021-04-30 | $838.6m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2021-02-01 to 2021-04-30 | $146.7m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 9 months2020-08-01 to 2021-04-30 | $424.8m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months2021-02-01 to 2021-04-30 | $148.8m | us-gaap:GrossProfit |
| Gross profit | 9 months2020-08-01 to 2021-04-30 | $413.8m | us-gaap:GrossProfit |
| Research and development | 3 months2021-02-01 to 2021-04-30 | $11.3m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 9 months2020-08-01 to 2021-04-30 | $31.4m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months2021-02-01 to 2021-04-30 | $90.8m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months2020-08-01 to 2021-04-30 | $256.1m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2021-02-01 to 2021-04-30 | $46.7m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2020-08-01 to 2021-04-30 | $126.3m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2021-02-01 to 2021-04-30 | $131.0k | us-gaap:InterestExpense |
| Interest expense | 9 months2020-08-01 to 2021-04-30 | $288.0k | us-gaap:InterestExpense |
| Income tax | 3 months2021-02-01 to 2021-04-30 | $10.2m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2020-08-01 to 2021-04-30 | $27.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2021-02-01 to 2021-04-30 | $37.3m | us-gaap:NetIncomeLoss |
| Net income | 9 months2020-08-01 to 2021-04-30 | $101.6m | us-gaap:NetIncomeLoss |
| Diluted shares (weighted) | 3 months2021-02-01 to 2021-04-30 | 52,449,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2020-08-01 to 2021-04-30 | 52,341,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2020-08-01 to 2021-04-30 | $154.9m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months2020-08-01 to 2021-04-30 | $21.4m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 9 months2020-08-01 to 2021-04-30 | $34.3m | us-gaap:PaymentsOfDividends |
| Share repurchases | 9 months2020-08-01 to 2021-04-30 | $3.6m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2021-04-30 | $321.8m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2021-04-30 | $621.1m | us-gaap:AssetsCurrent |
| Total assets | At period end2021-04-30 | $1.26bn | us-gaap:Assets |
| Current liabilities | At period end2021-04-30 | $221.1m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2021-04-30 | $308.6m | us-gaap:Liabilities |
| Shareholders' equity | At period end2021-04-30 | $951.6m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0000746598-21-000067. Last ingested by Listed: Nov 9, 2026, 17:29 ET. Listed shows no prices and gives no investment advice.